OcuTerra OTT166-201

A short video from the Dr. David Tanzer, Chief Medical Officer of OcuTerra summarizing the OTT166 Eye drops trial.

Previous Video
Bioteching with Stephanie Gonzalez
Bioteching with Stephanie Gonzalez

Stephanie Gonzalez, Vice President and Head of Biotech Operations for EMEA, compares her preparation for co...

Next Video
Meet Anthony Bohnert - Global TA Section Head, Respiratory
Meet Anthony Bohnert - Global TA Section Head, Respiratory

Anthony shares how Parexel's flexibility allows him to keep some clinical responsibilities. By receiving mo...